Skip to content
Regulatory Affairs advanced

Regulatory Science for Peptide Drugs

Emerging regulatory science concepts for evaluating peptide drug products. This peptide or oligopeptide is studied for its biological activity, structure-act...

By Encyclopeptide Editorial | 1 min read
regulatory-science framework evaluation science-based policy

Overview

Regulatory science provides the scientific foundation for regulatory decision-making regarding peptide drugs.

Key Areas

Product Quality

  • Characterization standards
  • Stability assessment
  • Comparability frameworks

Safety Evaluation

  • Immunogenicity assessment
  • Toxicity evaluation
  • Risk-based approaches

Efficacy Assessment

  • Clinical endpoints
  • Biomarker validation
  • Adaptive trial designs

Emerging Concepts

  • Quality by design (QbD)
  • Process analytical technology (PAT)
  • Continuous manufacturing
  • Digital twins
  • AI in regulation

Test Your Knowledge

Reinforce what you learned about Regulatory Science for Peptide Drugs with interactive quizzes on Wikipept.

Take a Quiz on Wikipept